Tag Archives: Science’s

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »

Water and Homeopathy: Latest Discoveries at Science’s Cutting Edge

By Dana Ullman, MPH, CCH and Lionel Milgrom, Ph.D., RHom, MARH If the common physician, scientist and educated consumer were to believe Wikipedia, they would assume that there is absolutely no research that shows the efficacy of homeopathic medicines in the treatment of any ailment. Furthermore, they would conclude homeopathic medicines are so small in… Read More »